FDA to Vitamin Makers: Supplements Can't Cure Alzheimer's, Cancer, Opioid Addiction




  • In Science
  • 2019-02-11 22:57:33Z
  • By Brittany Shoot
 

The United States Food and Drug Administration (FDA) issued more than a dozen warnings and advisory letters on Monday aimed at the makers of various dietary supplements that promise to cure, prevent, or treat Alzheimer's disease, as well as other serious conditions such as cancer and opioid addiction. The FDA, which is responsible for the assuring the safety and efficacy of supplements, warns that the agency has not evaluated these products as safe and effective in the treatment of incurable conditions including Alzheimer's.

Supplements are big business, as three out of four Americans consume some type of dietary supplement, such as a daily vitamin or herbal supplement, as part of their regular routine. FDA Commissioner Scott Gottlieb explained that the supplement market may have outpaced the agency's ability to properly regulate the volume and variety of products hitting the market, and that the agency is working toward more rapid response methods of issuing consumer warnings and halting the production and distribution of products marketed using fraudulent claims to prevent or cure conditions that cannot be treated with over-the-counter supplements. Additionally, he reiterated that consumers are advised to be wary of any products that promise extraordinary results without providing any proof and are encouraged to report unregulated products to the FDA's MedWatch program.

As is well known, there is no cure for Alzheimer's disease, which the FDA spelled out in its warnings Monday. In reference to the numerous warnings issued on Monday, Gottlieb noted, "Any products making unproven drug claims could mislead consumers to believe that such therapies exist and keep them from accessing therapies that are known to help support the symptoms of the disease, or worse as some fraudulent treatments can cause serious or even fatal injuries."

COMMENTS

More Related News

Intercept Pharmaceuticals Investors Strap In for a Wild Ride
Intercept Pharmaceuticals Investors Strap In for a Wild Ride

Top-line data from the Regenerate trial cleared an important hurdle, but the race to launch the first NASH treatment isn't over yet.

Free Therapy Dog Sessions Help Those Affected By Alzheimer's Smile, Engage and Transform
Free Therapy Dog Sessions Help Those Affected By Alzheimer's Smile, Engage and Transform

Alzheimer's Foundation of America's therapy dog classes are free and open to the public

Young Blood Scam: FDA Warns Against Unproven Anti-Aging Transfusions
Young Blood Scam: FDA Warns Against Unproven Anti-Aging Transfusions

If thereported claims about those treatments sound too good to be true, that'sbecause they are, according to the FDA

Don't Buy Young People's Blood to Stop Aging, FDA Warns
Don't Buy Young People's Blood to Stop Aging, FDA Warns

Don't Buy Young People's Blood to Stop Aging, FDA Warns

Philippines revokes Sanofi
Philippines revokes Sanofi's product license for dengue vaccine

The Philippines has permanently halted the sale, distribution and marketing of Sanofi's dengue vaccine in the country after the French drug maker failed to meet the directives of regulators. Food and Drug Administration (FDA) Director General Nela Charade Puno said on Tuesday registration certificates for Dengvaxia products have been revoked because of Sanofi's "brazen defiance" of the agency's directives. The FDA said Sanofi failed to comply with post marketing authorization requirements as of December last year.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Science

facebook
Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.